BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamel M, El-Sayed A. Utilization of herpesviridae as recombinant viral vectors in vaccine development against animal pathogens. Virus Res 2019;270:197648. [PMID: 31279828 DOI: 10.1016/j.virusres.2019.197648] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Li R, Shao G, Xie Z, Hu Z, Feng K, He J, Wang H, Fu J, Zhang X, Xie Q. Construction and Immunogenicity of a Recombinant Pseudorabies Virus Expressing SARS-CoV-2-S and SARS-CoV-2-N. Front Vet Sci 2022;9:920087. [DOI: 10.3389/fvets.2022.920087] [Reference Citation Analysis]
2 Shao G, Xie Z, Liang M, Liu Y, Song C, Feng K, Zhang X, Lin W, Fu J, Xie Q. Efficacy of recombinant Newcastle disease virus expressing HA protein of H9N2 Avian influenza virus in respiratory and intestinal tract. Poultry Science 2022. [DOI: 10.1016/j.psj.2022.102078] [Reference Citation Analysis]
3 Li Q, Cheng S, Li G, Liu P, Zou Z, Hou X, Latigo V, Li L, Guo X, Hu G, Huang H, Khan A, Liu P. Preparation of polyclonal antibodies against chemically synthesized ApxIA and ApxIVA toxins and their diagnostic efficacy in the experimentally injected mice. Journal of King Saud University - Science 2022;34:101999. [DOI: 10.1016/j.jksus.2022.101999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Aziz IM, Farrag MA, Bhat R, Ahmed A, Alkubaisi NA, Alzayed RM, Dudin GA, Almajhdi FN. Development and Validation of Rapid In-House Diagnostic ELISA Kits for Detection of Human Orthopneumovirus in Clinical Samples. Diagnostics 2022;12:912. [DOI: 10.3390/diagnostics12040912] [Reference Citation Analysis]
5 Tang N, Zhang Y, Shen Z, Yao Y, Nair V. Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines. CRISPR J 2021;4:477-90. [PMID: 34406035 DOI: 10.1089/crispr.2021.0017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang X, Bo Z, Meng C, Chen Y, Zhang C, Cao Y, Wu Y. Generation and Evaluation of Recombinant Thermostable Newcastle Disease Virus Expressing the HA of H9N2 Avian Influenza Virus. Viruses 2021;13:1606. [PMID: 34452473 DOI: 10.3390/v13081606] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
7 Zhang Q, Song X, Ma P, Lv L, Zhang Y, Deng J, Zhang Y. Human Cytomegalovirus miR-US33as-5p Targets IFNAR1 to Achieve Immune Evasion During Both Lytic and Latent Infection. Front Immunol 2021;12:628364. [PMID: 33746965 DOI: 10.3389/fimmu.2021.628364] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
8 Wang W, Meng Q, Li Q, Liu J, Zhou M, Jin Z, Zhao K. Chitosan Derivatives and Their Application in Biomedicine. Int J Mol Sci 2020;21:E487. [PMID: 31940963 DOI: 10.3390/ijms21020487] [Cited by in Crossref: 70] [Cited by in F6Publishing: 153] [Article Influence: 35.0] [Reference Citation Analysis]
9 Kamel M, El-Sayed A. Toward peste des petits virus (PPRV) eradication: Diagnostic approaches, novel vaccines, and control strategies. Virus Res 2019;274:197774. [PMID: 31606355 DOI: 10.1016/j.virusres.2019.197774] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
10 El-Sayed A, Kamel M. Advances in nanomedical applications: diagnostic, therapeutic, immunization, and vaccine production. Environ Sci Pollut Res Int 2020;27:19200-13. [PMID: 31529348 DOI: 10.1007/s11356-019-06459-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 10.7] [Reference Citation Analysis]